Of the nine MS risk genes tested, five were significantly responsive to serum depletion in males, and none in females (CD40, ADCY3, ZC3HAV1, CLECL1 and IKZF3; Figure 6, p < 0.05). The gene discussed is CLECL1; the disease is myeloid sarcoma.